| ردیف |
عنوان |
کد رهگیری |
نمایه |
تاریخ انتشار |
دوره (Volum) |
شماره |
ضریب تاثیر |
کد طرح های مرتبط |
| 1 | The impaired gene expression of adenosine monophosphate-activated kinase (AMPK), a key metabolic enzyme in leukocytes of newly diagnosed rheumatoid arthritis patients | 14589 | ISI | 1398/09/10 | | | 2.107 | 95708 |
| 2 | The Association between the Plasma Sugar and Lipid Profile with the Gene Expression of the Regulatory Protein of mTOR (Raptor) in Patients with Rheumatoid Arthritis | 16401 | ISI | 1399/04/04 | https://doi.org/10.1080/08820139.2020.1781160 | 6 | 2.511 | 96604 |
| 3 | Evaluation serum levels of Insulin Growth Factor‑1 (IGF‑1) and its
association with clinical parameters in severe COVID‑19 | 17725 | ISI | 1400/11/11 | https://doi.org/10.1007/s10787-021-00908-6 | 1 | 4.473 | 990599 |
| 4 | Increased plasma levels of CCL20 in peripheral blood of rheumatoid
arthritis patients and its association with clinical and laboratory
parameters | 17814 | ISI | 1401/01/16 | 10.1007/s10067-021-05899-x | 1 | 2.98 | 4000290 |
| 5 | Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis | 18420 | ISI | 1401/04/14 | | | 5.714 | 4000445 |
| 6 | Difference in the Cytomegalovirus-related Clinical Laboratory Findings Between Patients With Bone Marrow and Kidney Transplantations | 18425 | علمی پژوهشی | 1400/05/29 | https://doi.org/10.32598/rmm.9.3.1222.1 | 3 | | 980781 |
| 7 | A review on the immune responses against novel emerging coronavirus (SARS-CoV-2) | 18611 | ISI | 1401/01/29 | https://doi.org/10.1007/s12026-021-09198-0 | 3 | 4.505 | |
| 8 | Partners in crime: Autoantibodies complicit in COVID‐19 pathogenesis | 18616 | ISI | 1401/09/14 | | | 11.043 | |
| 9 | Investigating the correlation of the NF-κB and FoxP3 gene expression with the plasma levels of pro- and anti-inflammatory cytokines in rheumatoid arthritis patients | 18697 | ISI | 1401/11/15 | https://doi.org/10.1007/s10067-023-06521-y | | 3.65 | 95709 |
| 10 | CXCL9 and its Receptor CXCR3, an Important Link
Between Inflammation and Cardiovascular Risks
in RA Patients | 19421 | ISI | 1402/05/14 | doi: 10.1007/s10753-023-01884-5 | | 5.1 | 4010153 |
| 11 | Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone | 19604 | ISI | 1402/09/13 | | | 3.4 | 4000650 |
| 12 | CXCL9 and NT‑proBNP, a notable link between inflammatory mediator
and cardiovascular disease biomarker in rheumatoid arthritis | 19672 | ISI | 1402/09/04 | https://doi.org/10.1007/s10067-023-06826-y | 1 | 3.4 | 4010153 |
| 13 | Increased gene expression of CCR6 and RORγt in
peripheral blood cells of rheumatoid arthritis patients
and their correlation with anti‐cyclic citrullinated peptide
and disease activity | 19677 | ISI | 1402/09/15 | https://doi.org/10.1002/iid3.1112 | 12 | 3.2 | 4000290 |
| 14 | Assessing the gene expression of the adenosine 5′-monophosphateactivated protein kinase (AMPK) and its relation with the IL-6 and IL-10
plasma levels in COVID-19 patients | 19688 | ISI | 1402/08/02 | | | 2.8 | 4010214 |
| 15 | The development of anticyclic citrullinated peptide
(anti‐CCP) antibody following severe COVID‐19 | 20006 | ISI | 1403/02/17 | DOI: 10.1002/iid3.1276 | | 3.2 | 4000648 |
| 16 | کاهش بیان p53 با کاهش بیان zyxin در سرطان پستان همراه است | 20157 | ISI | 1403/05/11 | | | 2.1 | 4000317 |
| 17 | Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients | 20200 | ISI | 1403/05/30 | https://onlinelibrary.wiley.com/doi/10.1111/jcmm.70028 | | 4.3 | 4020751 |
| 18 | miR-6089 may prevent the inflammatory events leading to cardiovascular disorders in RA patients | 20242 | ISI | 1403/06/02 | https://doi.org/10.1016/j.heliyon.2024.e36763 | 17 | 3.4 | 4010153 |
| 19 | Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression | 20313 | ISI | 1403/06/14 | | | 4.6 | 4000423 |
| 20 | The Effect of Disease-modifying Antirheumatic Drugs (DMARDs) on the Expression and Methylation Status of the
FOXO1 gene in Newly Diagnosed Patients
with Rheumatoid Arthritis | 20607 | ISI | 1403/07/09 | | | 0.3 | |
| 21 | Differential Expression of Galectin-3, Caspase-1, and Phosphorylated P53: Diagnostic Biomarkers for Basal Cell Carcinoma: A Case-Control Study | 21508 | ISI | 1404/08/15 | | | 2.1 | |
